Cytokinetics, Incorporated - Common Stock — Quarterly Financial Statistics (NASDAQ:CYTK) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -131.62 M-128.24 M-107.5 M-142.65 M-145.46 M -523.85 M Cash from investing activities 105.96 M52.88 M-70.98 M-71.19 M145.49 M 56.2 M Cash from financing activities 4.75 M78.53 M330.47 M110.7 M7.77 M 527.47 M Free cash flow -131.62 M-128.24 M-107.5 M-142.65 M-145.46 M -523.85 M

News

All You Need to Know About Cytokinetics (CYTK) Rating Upgrade to Buy

Wall Street Analysts Think Cytokinetics (CYTK) Could Surge 30.54%: Read This Before Placing a Bet

Apple Shines As It Nears Fresh High, Leads 18 Hot Picks Onto Best Stock Lists

Will Myqorzo Drive Cytokinetics Higher Despite Competitive Pressure?

AMD, Micron Spearhead Chip Sector Surge, Lead 23 Hot Prospects To Best Stock Lists

Entertainment Stocks Madison Square Garden, Sphere Rally To New Highs

Cytokinetics Gains 18.4% Year to Date: How to Play the Stock?

Can BMY's Camzyos Strengthen Its Cardiovascular Portfolio?

Edgewise Bounds Between Double-Digit Losses And Gain — What's Going On?

A veteran investor is kicking Tesla out of the ‘Magnificent Seven’ — replacing it with this tech giant

Top Analyst Reports for Costco, Lam Research & KLA

Cytokinetics, Incorporated (CYTK) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript